Neuroscientists Threaten to Boycott Brain Project

More than 250 European researchers sign a letter criticizing the European Commission’s $1.6 billion effort to create a computer simulation of the human brain.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, WYGLIFThe European Commission’s (EC) Human Brain Project (HBP) is attracting criticism from leading neuroscientists. More than 250 European researchers have signed an open letter calling on the EC to demand transparency and accountability in the ranks of the project’s governing body, and the signatories threaten to not apply for funding through the project if problems with it aren’t corrected. “We wish to express the view that the HBP is not on course and that the European Commission must take a very careful look at both the science and the management of the HBP before it is renewed,” the letter read.

At issue is the HBP’s goal to create a computer simulation of the brain by developing technologies that enable the sharing and integrating of neuroscience data, rather than funding cognitive research that deals with high-level brain functions such as thought, consciousness, and behavior. “The notion that we know enough about the brain to know what we should simulate is crazy, quite frankly,” Peter Dayan, a computational neuroscientist at University College London, told ScienceInsider.

Henry Markram of the Swiss Federal Institute of Technology in Lausanne leads the HBP and told BBC News that opposition to the project is “premature.” He contests that the signatories of the open letter are simply reticent to adopt a new approach to conducting neuroscience research. “We're dealing here with a new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies